Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer	HER2-negative Breast Cancer; Neoadjuvant Chemotherapy	Recruiting	Phase 2 / Phase 3	2021-08-12		NCT04576143

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Changxing People's Hospital	7
First Affiliated Hospital of Zhejiang University	201
Huizhou Municipal Central Hospital	21
Second Affiliated Hospital, Zhejiang University, School of Medicine	561
Women's Hospital School Of Medicine Zhejiang University	60
Zhejiang Provincial People's Hospital	74

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
2nd Affiliated Hospital, School of Medicine, Zhejiang University	Hangzhou	China	6